GGrantIndex
← Leaderboards

Eric Hollander

Mount Sinai School Of Medicine Of Cuny

Google Scholar ↗PubMed ↗ORCID ↗
$7,400,315
Attributed
$7,400,315
Total exposure
38
Grants
20
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.1M · FY2005–07
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07

Funding mix

By agency

NIH$13,614,866 · 38
FDA$370,699 · 1

By mechanism

U54$11,129,490 · 4
R01$1,032,433 · 3
M01$857,029 · 29
R21$508,500 · 1
T32$373,746 · 1
R03$84,367 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Human Subject”

Research focus

Human SubjectClinical ResearchMental Disorder ChemotherapyHuman Therapy EvaluationBehavioral /Social Science Research TagClinical TrialsAutismPlacebosAdolescence (12-20)Drug Screening /EvaluationSerotoninSign /SymptomFluoxetineValproateFundingResourcesSerotonin InhibitorSourceUnited States National Institutes Of HealthChild Mental DisordersResearch PersonnelObsessive Compulsive DisorderCompulsive BehaviorComputer Retrieval Of Information On Scientific Projects Database

Grant awards (83)

FLUOXETINE vs. PLACEBO IN CHILD/ADOLESCENT AUTISTIC DISORDER$299,924
U54 · FY2007 · MH · contact PI
CLINICAL CORE$249,211
U54 · FY2007 · MH · contact PI
ADMINISTRATIVE CORE$203,463
U54 · FY2007 · MH · contact PI
GREATER NEW YORK AUTISM CENTER OF EXCELLENCE - CLINICAL CORE$22,490
M01 · FY2007 · RR · contact PI
OXYTOCIN VS PLACEBO ON RESPONSE INHIBITION AND FACE PROCESSING IN AUTISM$9,725
M01 · FY2007 · RR · contact PI
INTRANASAL OXYTOCIN CHALLENGE IN BORDERLINE PERSONALITY$8,511
M01 · FY2007 · RR · contact PI
DIVALPROEX SODIUM ER IN ADULT AUTISM$6,078
M01 · FY2007 · RR · contact PI
FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDER$3,040
M01 · FY2007 · RR · contact PI
EARLY PHARMACOLOGIC INTERVENTION IN AUTISM: FLUOXETINE IN PRESCHOOL CHILDREN$2,431
M01 · FY2007 · RR · contact PI
TOPIRAMATE IN THE TREATMENT OF PATHOLOGICAL GAMBLING$607
M01 · FY2007 · RR · contact PI
Greater New York Autism Research Center of Excellence$1,553,389
U54 · FY2006 · MH · contact PI
FLUOXETINE vs. PLACEBO IN CHILD/ADOLESCENT AUTISTIC DISORDER$380,354
U54 · FY2006 · MH · contact PI
FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDER$370,699
R01 · FY2006 · FD · contact PI
CLINICAL CORE$331,183
U54 · FY2006 · MH · contact PI
ADMINISTRATIVE CORE$238,948
U54 · FY2006 · MH · contact PI
Training in Psychopharmacology and Outcomes Research$114,450
T32 · FY2006 · MH · contact PI
TOPIRAMATE IN THE TREATMENT OF PATHOLOGICAL GAMBLING$33,780
M01 · FY2006 · RR · contact PI
DIVALPROEX SODIUM VS PLACEBO IN CHILD/ADOLESCENT AUTISM$20,911
M01 · FY2006 · RR · contact PI
GREATER NEW YORK AUTISM CENTER OF EXCELLENCE - CLINICAL CORE$17,159
M01 · FY2006 · RR · contact PI
FLUXOETINE VS PLACEBO IN ADULT AUTISTIC DISORDER$8,579
M01 · FY2006 · RR · contact PI
AN FMRI STUDY OF EFFECTS OF OXYTOCIN VS PLACEBO IN AUTISM$6,434
M01 · FY2006 · RR · contact PI
DIVALPROEX SODIUM ER IN ADULT AUTISM$3,753
M01 · FY2006 · RR · contact PI
TOPIRAMATE AUGMENTATION IN THE TREATMENT OF OCD$3,753
M01 · FY2006 · RR · contact PI
FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDER$1,073
M01 · FY2006 · RR · contact PI
Greater New York Autism Research Center of Excellence$1,646,312
U54 · FY2005 · MH
FLUOXETINE vs. PLACEBO IN CHILD/ADOLESCENT AUTISTIC DISORDER$377,579
U54 · FY2005 · MH
CLINICAL CORE$329,530
U54 · FY2005 · MH
ADMINISTRATIVE CORE$235,764
U54 · FY2005 · MH
Training in Psychopharmacology and Outcomes Research$105,961
T32 · FY2005 · MH
GREATER NEW YORK AUTISM CENTER OF EXCELLENCE - CLINICAL CORE$22,951
M01 · FY2005 · RR
DIVALPROEX SODIUM VS PLACEBO IN CHILD/ADOLESCENT AUTISM$15,703
M01 · FY2005 · RR
OPEN-LABEL TRIAL OF DIVALPROEX SODIUM EXTENDED RELEASE IN BORDERLINE PERSONAL$15,703
M01 · FY2005 · RR
EFFICACY OF ESCITALOPRAM IN THE TREATMENT OF INTERNET ADDICTION$13,891
M01 · FY2005 · RR
IMAGING SEROTONIN FUNCTION IN PATHOLOGICAL GAMBLING$8,456
M01 · FY2005 · RR
SERTALINE IN THE TREATMENT OF BINGE EATING DISORDER AMONG OBESE CHILDREN AND$6,039
M01 · FY2005 · RR
FLUXOETINE VS PLACEBO IN ADULT AUTISTIC DISORDER$5,436
M01 · FY2005 · RR
LEVETIRACETAM VS PLACEBO IN CHILD AND ADOLESCENT AUTISTIC DISORDER$5,436
M01 · FY2005 · RR
ZIPRASIDONE (GEODON) AUGMENTATION IN SEROTONIN REUPTAKE INHIBITOR-RESISTANT OB$4,227
M01 · FY2005 · RR
TOPIRAMATE IN THE TREATMENT OF PATHOLOGICAL GAMBLING$1,812
M01 · FY2005 · RR
FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDER$0
R01 · FY2005 · FD
Greater New York Autism Research Center of Excellence$1,638,354
U54 · FY2004 · MH
FLUOXETINE vs. PLACEBO IN CHILD/ADOLESCENT AUTISTIC DISORDER$374,595
U54 · FY2004 · MH
CLINICAL CORE$327,927
U54 · FY2004 · MH
ADMINISTRATIVE CORE$232,674
U54 · FY2004 · MH
Training in Psychopharmacology and Outcomes Research$103,208
T32 · FY2004 · MH
Efficacy of Escitalopram in the Treatment of Internet Addiction$22,295
M01 · FY2004 · RR
Open-Label Trial of Divalproex Sodium Extended Release in Borderline Personal...$15,482
M01 · FY2004 · RR
Fluxoetine vs. Placebo in Adult Autistic Disorder$10,529
M01 · FY2004 · RR
Ziprasidone (Geodon) Augmentation in Serotonin Reuptake Inhibitor-Resistant Ob..$8,671
M01 · FY2004 · RR
Divalproex Sodium vs. Placebo in Child/Adolescent Autism$8,050
M01 · FY2004 · RR
Levetiracetam vs. Placebo in Child and Adolescent Autistic Disorder$5,574
M01 · FY2004 · RR
Sertaline in the Treatment of Binge Eating Disorder Among Obese Children and...$5,574
M01 · FY2004 · RR
Greater New York Autism Center of Excellence - Clinical Core$2,477
M01 · FY2004 · RR
Pharmacotherapy of Adolescent Body Dysmorphic Disorder$619
M01 · FY2004 · RR
Greater New York Autism Research Center of Excellence$1,577,695
U54 · FY2003 · MH
FLUOXETINE vs. PLACEBO IN CHILD/ADOLESCENT AUTISTIC DISORDER$381,572
U54 · FY2003 · MH
CLINICAL CORE$350,342
U54 · FY2003 · MH
ADMINISTRATIVE CORE$231,174
U54 · FY2003 · MH
Divalproex Sodium/Placebo In Child/Adolesent Autism$169,500
R21 · FY2003 · NS
Greater New York Autism Research Center of Excellence$169,500
U54 · FY2003 · MH
Training in Psychopharmacology and Outcomes Research$50,127
T32 · FY2003 · MH
SEROTONIN/NOREPINEPHRINE FUNCTION PATHOLOGICAL GAMBLING$206,718
M01 · FY2002 · RR
Divalproex Sodium/Placebo In Child/Adolesent Autism$169,500
R21 · FY2002 · NS
PHARMACOTHERAPY OF ADOLESCENT BODY DYSMORPHIC DISORDER$117,455
R01 · FY2002 · MH
FLUVOXAMINE CR IN OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2002 · RR
PAROXETINE IN GENERALIZED ANXIETY DISORDER$0
M01 · FY2002 · RR
DIVALPROEX SODIUM/PLACEBO IN BORDERLINE PERSONALITY DIS$0
M01 · FY2002 · RR
NEUROTRANSMITTERS &NEUROPSYCHIATRIC INVESTIGATIONS--AUTISM &ASPERGERS SYNDROME$0
M01 · FY2002 · RR
SEROTONIN &NOREPINEPHRINE FUNCTION PATHOLOGICAL GAMBLING$206,718
M01 · FY2001 · RR
Divalproex Sodium/Placebo In Child/Adolesent Autism$169,500
R21 · FY2001 · NS
PHARMACOTHERAPY OF ADOLESCENT BODY DYSMORPHIC DISORDER$118,094
R01 · FY2001 · MH
FLUVOXAMINE CR IN OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2001 · RR
PAROXETINE IN GENERALIZED ANXIETY DISORDER$0
M01 · FY2001 · RR
DIVALPROEX SODIUM/PLACEBO IN BORDERLINE PERSONALITY DIS$0
M01 · FY2001 · RR
NEUROTRANSMITTERS &NEUROPSYCHIATRIC INVESTIGATIONS--AUTISM &ASPERGERS SYNDROME$0
M01 · FY2001 · RR
SEROTONIN/NOREPINEPHRINE FUNCTION--PATHOLOGICAL GAMBLING$310,805
R01 · FY2000 · DA
PHARMACOTHERAPY OF ADOLESCENT BODY DYSMORPHIC DISORDER$115,380
R01 · FY2000 · MH
DIVALPROEX SODIUM/PLACEBO IN BPD$84,367
R03 · FY2000 · MH
NEUROTRANSMITTERS &NEUROPSYCHIATRIC INVESTIGATIONS--AUTISM &ASPERGERS SYNDROME$68,788
M01 · FY2000 · RR
SEROTONIN &NOREPINEPHRINE FUNCTION PATHOLOGICAL GAMBLING$47,556
M01 · FY2000 · RR
FLUVOXAMINE CR IN OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2000 · RR
PAROXETINE IN GENERALIZED ANXIETY DISORDER$0
M01 · FY2000 · RR
DIVALPROEX SODIUM/PLACEBO IN BORDERLINE PERSONALITY DIS$0
M01 · FY2000 · RR